Revolution Medicines RVMD Earnings Call Transcripts

NASDAQ RVMD
$187.60 -1.12 (-0.59%)
As of: Oct 29, 2026 · 2:29 PM EDT
4 earnings calls on file for Revolution Medicines, from Nov 5, 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Revolution Medicines Q2 2026 Earnings Call

Aug 5, 2026 7,750 words · 34 min read
  • Ryan AsaySenior Vice President, Corporate Affairs
  • Mark GoldsmithChairman and Chief Executive Officer
  • Alan SandlerChief Development Officer
  • Jack AndersChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Revolution Medicines Earnings Call Transcripts

Calls4
LatestAug 5, 2026
SinceNov 5, 2025

Fiscal 2026

Fiscal 2025

All 4 Revolution Medicines transcripts Register to get access to Revolution Medicines’s earnings call transcripts.